Cost-effectiveness of interferon treatment for hepatitis C.
van Leeuwen
D J
DJ
D000998:Antiviral Agents / Q000191:economics* / Q000627:therapeutic use; D001706:Biopsy / Q000191:economics; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000191:economics* / Q000473:pathology; D006801:Humans; D007372:Interferons / Q000191:economics* / Q000627:therapeutic use; D014481:United States
D000998:Antiviral Agents; D007372:Interferons